Division of Cardiology, Showa University Northern Yokohama Hospital, Kanagawa, Japan.
Division of Cardiology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
J Cardiol. 2022 Dec;80(6):505-510. doi: 10.1016/j.jjcc.2022.07.002. Epub 2022 Jul 27.
Recent retrospective investigations have suggested that optical coherence tomography (OCT) enables the diagnosis of underlying acute coronary syndrome (ACS) causes such as plaque rupture, plaque erosion, and calcified nodule. The relationships of these etiologies with clinical outcomes, and the clinical utility of OCT-guided primary percutaneous coronary intervention (PCI) are not systematically studied in real-world ACS treatment settings.
The TACTICS registry is an investigator-initiated, prospective, multicenter, observational study to be conducted at 21 hospitals in Japan. A total of 700 patients with ACS (symptom onset within 24 h) undergoing OCT-guided primary PCI will be enrolled. The primary endpoint of the study is to identify the underlying causes of ACS using OCT-defined morphological assessment of the culprit lesion. The key secondary clinical endpoints are hazard ratios of the composite of cardiovascular death, non-fatal myocardial infarction, heart failure, or ischemia-driven revascularization in patients with underlying etiologies at the 12- and 24-month follow-ups. The feasibility of OCT-guided primary PCI for ACS will be assessed by the achievement rates of optimal post-procedural results and safety endpoints.
The TACTICS registry will provide an overview of the underlying causes of ACS using OCT, and will reveal any difference in clinical outcomes depending on the underlying causes. The registry will also inform on the feasibility of OCT-guided primary PCI for patients with ACS.
最近的回顾性研究表明,光学相干断层扫描(OCT)能够诊断潜在的急性冠状动脉综合征(ACS)病因,如斑块破裂、斑块侵蚀和钙化结节。这些病因与临床结局的关系,以及 OCT 指导下的直接经皮冠状动脉介入治疗(PCI)的临床应用,在真实世界的 ACS 治疗环境中尚未得到系统研究。
TACTICS 注册研究是一项由研究者发起的、前瞻性的、多中心、观察性研究,将在日本的 21 家医院进行。共纳入 700 例 ACS 患者(症状发作 24 小时内),接受 OCT 指导下的直接 PCI。该研究的主要终点是通过 OCT 对罪犯病变进行形态学评估,确定 ACS 的潜在病因。关键次要临床终点是在 12 个月和 24 个月随访时,根据病因,评估心血管死亡、非致死性心肌梗死、心力衰竭或缺血驱动的血运重建复合终点的风险比。OCT 指导下的 ACS 直接 PCI 的可行性将通过术后最佳结果和安全性终点的达标率来评估。
TACTICS 注册研究将通过 OCT 全面了解 ACS 的潜在病因,并揭示病因不同对临床结局的影响。该注册研究还将提供有关 OCT 指导下的 ACS 患者直接 PCI 可行性的信息。